Latest headlines
Vertex Pharmaceuticals News
The latest Vertex Pharmaceuticals (VRTX) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these VRTX headlines next to the live Vertex Pharmaceuticals Fear and Greed Index.
Latest Vertex Pharmaceuticals Headlines49
Vertex (VRTX) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
zacks.com · Jul 29, 2026
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
zacks.com · Jul 28, 2026
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
zacks.com · Jul 28, 2026
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
zacks.com · Jul 27, 2026
Vertex Pharmaceuticals (VRTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
zacks.com · Jul 22, 2026
Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today
zacks.com · Jul 20, 2026
Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching
fool.com · Jul 19, 2026
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com · Jul 16, 2026
Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals
fool.com · Jul 14, 2026
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors
zacks.com · Jul 13, 2026
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?
fool.com · Jul 13, 2026
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
marketbeat.com · Jul 11, 2026
Is This Biotech Stock a Buy Near Its 52-Week High?
fool.com · Jul 10, 2026
Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?
fool.com · Jul 10, 2026
Nvidia, Vertex Pharmaceuticals And More On CNBC's ‘Final Trades'
benzinga.com · Jul 9, 2026
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX
businesswire.com · Jul 8, 2026
Vertex's Crinetics Deal Balances Growth with Integration Risk
marketbeat.com · Jul 8, 2026
Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.
fool.com · Jul 8, 2026
Vertex Is Buying Crinetics for $10 Billion. Here's What Investors Need to Know.
fool.com · Jul 7, 2026
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
zacks.com · Jul 7, 2026
Vertex to Announce Second Quarter 2026 Financial Results on August 3rd
businesswire.com · Jul 7, 2026
Crinetics shares surge after Vertex agrees to $10B cash buyout
invezz.com · Jul 7, 2026
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Crinetics Pharmaceuticals, Inc. (CRNX)
newsfilecorp.com · Jul 7, 2026
Vertex Sees Over $5 Billion Peak Sales Potential From Crinetics Assets
benzinga.com · Jul 7, 2026
Breakfast News: Vertex Bets $10B to Win $5B a Year
fool.com · Jul 7, 2026
Why Crinetics Pharmaceuticals Shares Are Trading Higher By 99%; Here Are 20 Stocks Moving Premarket
benzinga.com · Jul 7, 2026
Vertex Pharmaceuticals Incorporated (VRTX) M&A Call Transcript
seekingalpha.com · Jul 7, 2026
Vertex Pharma Makes A $10 Billion Deal; Biotech Stock Doubles
investors.com · Jul 6, 2026
Crinetics Pharmaceuticals Stock Doubles After The Close: Here's Why
benzinga.com · Jul 6, 2026
Vertex to buy Crinetics in $10 billion deal
reuters.com · Jul 6, 2026
Vertex to Acquire Crinetics Pharmaceuticals
businesswire.com · Jul 6, 2026
Vertex Pharmaceuticals Stock Is Soaring and at a New All-Time High. Could It Still Be Heading Even Higher?
fool.com · Jul 6, 2026
While SpaceX Gets the Headlines, Smart Investors Are Loading Up on This Stock Instead
fool.com · Jul 5, 2026
Wall Street Bulls Look Optimistic About Vertex (VRTX): Should You Buy?
zacks.com · Jul 3, 2026
Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?
fool.com · Jul 3, 2026
Vertex Gets FDA Nod for Expanded Use of Casgevy in SCD & TDT
zacks.com · Jul 2, 2026
Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia
businesswire.com · Jul 1, 2026
US FDA approves Vertex's gene therapy for sickle cell disease in children as young as two
reuters.com · Jul 1, 2026
Dyne Therapeutics vs. Vertex Pharmaceuticals: Which Drug Innovator Stock Is a Better Buy in 2026?
fool.com · Jul 1, 2026
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
zacks.com · Jul 1, 2026
Vertex Pharmaceuticals Has One Of The Widest And Most Durable Moats In Biotech
seekingalpha.com · Jun 30, 2026
CRISPR Therapeutics AG vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Jun 27, 2026
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today
zacks.com · Jun 26, 2026
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today
zacks.com · Jun 24, 2026
Vertex Pharmaceuticals: Povetacicept May Redefine Growth Narrative (Rating Upgrade)
seekingalpha.com · Jun 24, 2026
Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up.
fool.com · Jun 20, 2026
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
zacks.com · Jun 18, 2026
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today
zacks.com · Jun 17, 2026
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock
zacks.com · Jun 17, 2026
Why Is Vertex Pharmaceuticals Up or Down Today?
When Vertex Pharmaceuticals (VRTX) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a VRTX move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Vertex Pharmaceuticals is up or down today.
How Vertex Pharmaceuticals News Affects the Price
News does not move the Vertex Pharmaceuticals (VRTX) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Vertex Pharmaceuticals Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Vertex Pharmaceuticals trading volume. That is the chain to watch: headline, sentiment, volume, then the VRTX price.
Trade the Vertex Pharmaceuticals News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Vertex Pharmaceuticals trading volume spike on a big story, check the Vertex Pharmaceuticals price history for context, follow the live VRTX price, see the Vertex Pharmaceuticals price prediction, and read the Vertex Pharmaceuticals Fear and Greed Index for mood.
How do you feel about Vertex Pharmaceuticals?
1DFrequently asked questions
Why is Vertex Pharmaceuticals up or down today?
What is the latest Vertex Pharmaceuticals news?
Where does Vertex Pharmaceuticals news come from?
How often is Vertex Pharmaceuticals news updated?
How does Vertex Pharmaceuticals news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.